PharmaSonics regulatory update

PharmaSonics received three U.S. patents covering its catheter-based ultrasound delivery technology that combines ultrasound energy with drugs and genes. No. 5,735,811 covers an apparatus and methods for ultrasonically enhanced fluid delivery using an ultrasonic catheter. No. 5,728,062 covers an apparatus and methods for vibratory intraluminal therapy using magnetostrictive transducers. No. 5,725,494 covers an apparatus and methods for ultrasonically enhanced intraluminal therapy. ...